SciELO - Scientific Electronic Library Online

 
vol.27 issue3Main clinical variables related to long-term mortality in COVID-19Vaccination against COVID-19 in Bogotá - Colombia: lessons and strategies in health pedagogy, risk communication and community participation,using behavioral sciences author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Infectio

Print version ISSN 0123-9392

Infect. vol.27 no.3 Bogotá July/Sept. 2023  Epub Sep 06, 2023

https://doi.org/10.22354/24223794.1141 

Artículos originales

The burden of tuberculosis disease in women, Colombia 2010-2018

La carga de enfermedad por Tuberculosis en mujeres, Colombia 2010-2018

Laura Plata-Casas1  2 
http://orcid.org/0000-0002-0375-8875

Oscar Gutiérrez-Lesmes3 
http://orcid.org/0000-0002-5181-0236

Favio Cala-Vitery1  4 
http://orcid.org/0000-0001-8953-9034

1 Universidad Jorge Tadeo Lozano, Bogotá Colombia

2 ORCID https://orcid.org/0000-0002-0375-8875

3 Universidad de los Llanos, Villavicencio Colombia. https://orcid.org/0000-0002-5181-0236

4 ORCID https://orcid.org/0000-0001-8953-9034


Abstract

Objective:

To estimate disability-adjusted life years in women attributable to tuberculosis in Colombia 2010-2018.

Methods:

A retrospective descriptive study was conducted. The following variables were studied: year of occurrence, age groups and origin. This study included 41,354 women who consulted in the hospital network and 2530 cases of mortality in women, registered in the country's vital statistics system. Using the abbreviated methodology proposed by the World Health Organization for measuring the burden of disease BD, years of life lost, years of life with disability and years of healthy life lost by women at the subnational level were estimated.

Results:

The Disability-Adjusted Life Years rate for the study period was 427.2 (95% II 353-492.3) per 100,000 women. Women of reproductive age (10 to 49 years old) account for 57.9 per cent of these. Departments such as Amazonas 1,426 (725.4-2,541.4) and Guajira 1,001.1 (693.3-1,260) had the highest rates (per 100,000 inhabitants). Twelve territorial entities have an increasing burden of disease.

Conclusions:

The rate of disability-adjusted life years due to tuberculosis in women for nine years was high and presents subnational differences perhaps due to large social or economic gaps or deficits in institutional or programmatic capacities.

Key words: Tuberculosis; Disability-Adjusted Life Years; women; Colombia

Resumen

Objetivo:

estimar los años de vida ajustados por discapacidad en mujeres atribuibles a Tuberculosis, Colombia 2010-2018.

Métodos:

Estudio descriptivo retrospectivo. Se estudiaron las variables: año de ocurrencia, grupos de edad y procedencia. Se incluyeron 41.354 mujeres que consultaron en la red hospitalaria y 2530 casos de mortalidad en mujeres, registrados en el sistema de estadísticas vitales del país. Mediante la metodología abreviada propuesta por la Organización Mundial de la Salud para la medición de la carga de la enfermedad, se estimaron los años de vida perdidos, años de vida con discapacidad y años de vida saludable perdidos por mujeres a nivel subnacional.

Resultados:

La tasa de años de vida ajustados por discapacidad del periodo de estudio fue de 427,2 (II95% 353-492,3) por cada 100.000 mujeres. Las mujeres en edad reproductiva (10 a 49 años) concentran el 57,9% de estos. Amazonas 1.426 (725,4-2541,4) y Guajira 1.001,1 (693,3-1260) presentaron las tasas más altas. Doce entidades territoriales tienen aumento de la carga de enfermedad.

Conclusiones:

La tasa de años de vida ajustados por discapacidad por tuberculosis en mujeres durante nueve años, fue alta y presenta diferencias subnacionales quizás debidas a las grandes brechas sociales o económicas o déficit de capacidades institucionales o programáticas.

Palabras clave: Tuberculosis; Años de Vida Ajustados por Discapacidad; mujeres; Colombia

Introduction

Tuberculosis (TB) is a preventable and curable communicable disease, which can affect the lung parenchyma or any other organ and generate continuous disability. This disease makes a major contribution to the global burden1. TB is expected to be the second leading cause of death from a single infectious agent, after COVID-192.

Globally, 9.9 million people developed TB in 2020, bringing the global death toll to 1.6 million; of these, 1.4 million in HIV-negative people (32% in women) and 187,000 in HIVpositive people (38% in women)3. The Region of the Americas reported an incidence rate of 30 and a mortality rate of 3.1 per 100,000 population. Colombia, the study site, bears a high burden of TB, presented incidence rate of 41 and mortality rate of 5 per 100,000 inhabitants2 (2) and 35.1% of cases of disease in women4. The high burden of TB is fueled by risk factors such as HIV, malnutrition, diabetes, among others5.

Colombia for its health diagnosis has as a strategic input the Health Situation Analysis ASIS, which uses simple indicators. The use of composite indicators such as Disability Adjusted Life Years (DALYs) to measure burden disease BD with the up dated methodology of the World Health Organization WHO is recent in the country. It has been used for the global burden in the Colombian Orinoquía6 and for the regionalized national order for TB7,8, however, although these include the variable sex, the specific behavior in women is not analyzed.

This disease also has serious consequences for women9, who are drastically and disproportionately affected10. Some factors related to gender inequality and systemic discrimination against women and girls may be influencing the impact that TB causes in Colombian women. These factors have been described: increased risk of malnutrition and food insecurity11, Increased illiteracy12, barriers to access and appropriate care, increased stigma13, increased TB rates in women with HIV14 and gender norms that require negotiation with their husbands when they are sick15, among others. These related factors are present in Colombia. Therefore, it is essential to estimate for the first time the burden that TB causes in Colombian women to identify their health status, progress in ending the epidemic, addressing the health system, and understanding the contextual issues influencing TB management in this population.

TB has been declared a priority in public health, where its common denominator is the inequitable distribution in the population and its overlap in regions with less development, in which it is important to address inequalities in women7. Studies in Colombia regarding gender gaps have shown that for women there are marked inequalities regarding their own income, economic participation rate, wages, among others16,17.

In this study, the objective was to determine the burden of TB attributable disease in women in Colombia 2010-2018. The results obtained allow us to specify that there is a knowledge gap regarding the realization and clear understanding of the BD in women in Colombia.

Materials and methods

A descriptive epidemiological study was conducted. The cases (morbidity and mortality) of TB occurred in the period 2010-2018 were obtained from the Integrated Information System for Social Protection SISPRO. For cases of mortality the source is the Vital Statistics System RUAF. To control for overestimation of morbidity, due to multiple consultations of the same woman to the hospital network, the database provided by the Ministry of Health and Social Protection was filtered by identification in the data source, before being delivered anonymously to researchers. We included all cases reported in the country in women during 2010-2018 at any age with morbidity and basic cause of death from any type of TB. The exclusion criteria were duplicate registrations and stillbirths and registrations in which the country of residence was not Colombia. All women diagnosed with tuberculosis in Colombia, regardless of the country of origin, are included in the database analyzed for this study. Considering the programmatic aspects of centralized drug distribution from the Ministry of Health and Social Protection and the strictly supervised shortened treatment, it is necessary to be included as a resident in the analyzed database. Given the above, no case was excluded from the database of Colombian women who have emigrated to different neighboring countries and who arrive in search of medical attention in Colombia. Based on these criteria, 41,354 women were selected to consult the country's hospital network and 2530 who died and were admitted to the RUAF.

Data analysis

We proceeded to identify the sociodemographic characteristics with respect to morbidity and mortality data by territorial entities TE. For mathematical calculations of years of life lost to premature death (YYL), Years Lived with Disability (YLD) and DALY correlations versus years of occurrence per entities, the SPSS™ program version 23 licensed was used. The construction of indicators by TE for each year and for the period of the study was carried out using as a numerator the number of cases and as denominator the population projection, according to the report of the census 2005 (considering that eight of the nine years of the study are under the projections of the 2005 census), by age group according to TE and a constant of 100,000 inhabitants, for the study period, the rates were calculated taking into account the mid-term population. The uncertainty intervals (II95%) for YLL, YLD and DALY were performed using Bootstrap (1000 samples) with bias corrections with the licensed XLSTAT 2021 software (Colombia 2021).

DALY s or Healthy Life Years Lost to TB

The indicator DALYs summarizes in a single value the data on the occurrence of mortality, morbidity, representing them as the healthy life time lost by a subject6. DALYs estimate the BD and are composed of the sum of YLL and YLD18. YLL are the years a person stops living when they die before meeting a theoretical life expectancy19. YLDs measure the deviation from health in any of the domains that a person lives in6. The calculation expression is:

In the previous expression DALYs (c,a,s,t) is the total Disability-Adjusted Life Years, YLD are Years Lived with Disability, YLL are Years of Life Lost, by cause (c) in age group (a), sex(s), and year t. This research used for the first time for Colombia, the updated metric of the indicator18, used by WHO in the Global Burden of Disease study GBD.

Bias control

The theoretical assumption of attributing mortality to the underlying cause was used to control for competitive risk bias. Regarding the underreporting of mortality, Dicker reports completeness for Colombia's vital statistics system, from 2004 to 201520. The underreporting bias in morbidity could not be corrected due to the lack of integrity measures of the vital statistics system21. With the inclusion of all reported cases in the different levels of care of the hospital network of all TE of the country, together with the reports of the Institute of Legal Medicine and Forensic Sciences, health care bias was mitigated.

Results

In the study period, 41,354 cases of women diagnosed with TB were reported in the country's hospital network and 2530 cases of mortality, corresponding to 37.4% and 29.7% of total TB records, respectively. The highest mortality rates were in Amazonas (23.7) and Guajira (21.3); Vichada reported no deaths in the study period and Guaviare had the lowest rate (1.7). The highest morbidity rates were in Amazonas (698.8) and Chocó (415.7) and lowest in Boyacá (52.5). By age group, women of childbearing age (10-49 years) accounted for 32.3% of mortality and 59.2% of morbidity (Table 1).

Table 1 Tuberculosis morbidity and mortality in women by territorial entity, Colombia, 2010-2018. 

Morbidity Mortality
Territorial entities Cases Adjusted rate Cases Adjusted rate
AMAZONAS 265 696,8 9 23,7
ANTIOQUIA 8306 266,5 354 11,4
ARAUCA 301 230,6 14 10,7
ATLANTICO 3354 279,2 231 19,2
BOGOTA 2709 72,1 271 7,2
BOLIVAR 1223 118,0 91 8,8
BOYACA 335 52,5 30 4,7
CALDAS 869 180,1 46 9,5
CAQUETA 484 204,4 26 11,0
CASANARE 376 211,5 18 10,1
CAUCA 901 130,1 47 6,8
CESAR 979 192,9 75 14,8
CHOCO 1029 415,7 36 14,5
CORDOBA 885 104,8 71 8,4
CUNDINAMARCA 970 73,7 61 4,6
GUAINIA 43 217,6 2 10,1
GUAVIARE 96 167,7 1 1,7
HUILA 916 160,0 60 10,5
GUAJIRA 1208 262,3 98 21,3
MAGDALENA 853 135,3 60 9,5
META 1297 274,8 85 18,0
NARIÑO 584 67,5 52 6,0
NORTE DE SANTANDER 1272 190,9 82 12,3
PUTUMAYO 343 198,6 10 5,8
QUINDÍO 676 245,0 38 13,8
RISARALDA 1681 364,7 73 15,8
SAN ANDRÉS 39 102,4 1 2,6
SANTANDER 1729 170,6 109 10,8
SUCRE 240 56,2 20 4,7
TOLIMA 1272 180,8 91 12,9
VALLE 6008 271,5 365 16,5
VAUPÉS 39 182,2 3 14,0
VICHADA 72 208,2 0 0,0
COLOMBIA 41354 159,8 2530 9,8

YLL: Deadly Effects of Tb

The YLL rate in women in Colombia during the study period was 370.1 years (II95% 315.9-416.8). By TE, in Amazonas it was 1189.9 (II95% 381.7-2093.9) and Guajira of 915.4 (II95% 635.5- 1175.8) presented the highest rates; Vichada reported no deaths and San Andrés had the lowest rate 44.4 (II95% 0-88.8). Women of reproductive age (10-49 years) are the most affected and concentrate 57.2% of these.

YLD: Nonfatal Effects of Tb

The YLD rate in women in Colombia during the study period was 57.1 (II95% 42.6-67.8). By TE Amazonas 236.4 (II95% 197.6- 285.4) and Guaviare 161.5 (II95% 107.8-239.4) presented the highest rates; and Boyacá had the lowest rate 17.5 (II95% 13.5-21.5). Women of reproductive age (10-49 years) are the most affected and concentrate 59.2% of these.

DALYs or Healthy Life Years Lost to TB

The DALY rate in women in Colombia during the study period was 427.2 (II95% 353-492.3). By TE, Amazonas 1426 (II95% 725.4-2541.4) and Guajira 1001.1 (II95% 693.3-1260) presented the highest rates; and Vichada had the lowest rate 69.1 (II 95% 48-98.6). Women of reproductive age (10-49 years) are the most affected and concentrate 57.9% of these. Table 2 shows data on YLL, YLD and DALY rates for the period 2010-2018.

Table 2 Rates of YLL, YLD and DALY for Tuberculosis in women by territorial entity, Colombia, 2010-2018*. 

Territorial entities YLL rate (II 95%) YLD rate (II 95%) DALY rate (II 95%)
Amazonas 1189,9 (381,7-2093,9) 236,4 (197,6-285,4) 1426 (725,4-2541,4)
Guajira 915,4 (635,5-1175,8) 85,7 (71,6-99,2) 1001,1 (693,3-1260)
Atlántico 676,1 (557,7-828) 81,1 (61,7-100,5) 757,2 (553,8-901,1)
Choco 603,1 (348,5-928,8) 138,4 (111,3-175) 741,5 (543,9-1230,7)
Meta 648,1 (483,1-804,6) 91,7 (69,2-115,4) 739,8 (607,3-907,7)
Risaralda 599,4 (449,7-733,7) 115,9 (92,8-134,8) 715,3 (541,8-907,4)
Valle 557,6 (461,2-648,6) 85 (72,6-103,7) 642,6 (534,9-783,8)
Cesar 530,5 (422,2-696,3) 64,7 (55,5-82,5) 595,2 (460,9-737,7)
Antioquia 428 (317,3-544) 84,8 (68,6-108,8) 512,8 (394,1-682,2)
Quindío 432,6 (224,5-687,1) 78,7 (58,4-97,4) 511,3 (310,8-719,6)
Tolima 433,8 (303,7-554,7) 60,5 (46,7-76,2) 494,3 (345,8-631,1)
Norte de Santander 412,5 (303,1-530,1) 62,5 (49,6-74,6) 475,1 (360,1-570,2)
Caquetá 403 (279,4-633,5) 68,7 (54,2-92,9) 471,7 (297,4-678,8)
Guaviare 304,2 (0-608,9) 161,5 (107,8-239,4) 466,2 (108,3-1077,1)
Colombia 370,1 (315,9-416,8) 57,1 (42,6-67,8) 427,2 (353-492,3)
Vaupés 366,2 (0-844,6) 60,3 (37,8-89,2) 426,5 (114,4-824)
Magdalena 378,1 (264,1-527,2) 46 (34,7-57) 424,2 (311,8-538,6)
Huila 338,6 (245,1-480,2) 53,7 (43,3-64,9) 392,3 (280,5-517,7)
Territorial entities YLL rate (II 95%) YLD rate (II 95%) DALY rate (II 95%)
Santander 327,9 (264,2-381) 55,5 (41,8-67,9) 383,4 (317,3-455,2)
Arauca 282,1 (156,2-450,9) 77,8 (67,2-90,5) 359,9 (198,9-509,8)
Caldas 298,7 (233,9-351,3) 45,5 (36,1-55,8) 344,1 (291,2-405,4)
Córdoba 308,4 (233,9-405,9) 34,3 (29,1-42,6) 342,7 (264,5-437,7)
Bolívar 291,3 (192,1-432,7) 39,3 (30,5-47,5) 330,6 (220,5-463,8)
Casanare 212,3 (52,7-397,9) 72,7 (53,9-85,4) 285 (140,2-396,3)
Cauca 237,4 (141,6-329,5) 44,5 (35,9-52,6) 281,9 (196,2-413,5)
Putumayo 190,1 (86,7-291) 67,9 (48,2-85,4) 257,9 (153,2-434)
Nariño 222,1 (158,9-285,6) 22,7 (16,8-26,8) 244,8 (188,2-303,9)
Bogotá 192,4 (158,5-228,6) 25,4 (19,8-30,7) 217,8 (168,5-263)
Sucre 173,9 (104,3-271,1) 19,2 (11,8-22,6) 193,1 (121,6-309,2)
Guainía 154,9 (0-305,2) 27,2 (18,2-36,2) 182,1 (21,6-492,2)
Boyacá 152,3 (104,5-210,9) 17,5 (13,5-21,5) 169,8 (126,7-231,9)
Cundinamarca 120,9 (79,9-161,4) 24,4 (18,4-29,8) 145,3 (110,1-188,9)
San Andrés 44,4 (0-88,8) 33,9 (19,7-46,2) 78,3 (26,3-206,9)
Vichada 0 (0-0) 68,8 (46,6-97,7) 69,1 (48-98,6)

*Abbreviations: YYL: years of life lost to premature death; YLD: Years Lived with Disability; DALY: Disability Adjusted Life Years

Pearson's correlation showed differences between TE, a group of 21 departments with negative correlation in which the burden of TB in women would be decreasing especially Valle (-0.843), Cauca (-0.601) and Magdalena (-0.555) (table 3) and another group of 12 TE that presented positive correlation where the burden of TB could denote an increase (increase in time), especially Caquetá (0.719), Cesar (0.716) and Guajira (0.546) (table 4).

Table 3 Negative Pearson correlation of DALY rates for Tuberculosis in women by territorial entity, Colombia, 2010-2018 

Territorial entities Coefficient
Valle -,843**
Colombia -,671*
Cauca -,601
Magdalena -,555
Bogotá -,550
Meta -,519
Casanare -,516
Bolívar -,448
Quindío -,444
Amazonas -,426
Santander -,360
Antioquia -,345
Putumayo -,339
Córdoba -,338
San Andrés -,290
Chocó -,279
Nariño -,267
Guainía -,172
Norte de Santander -,169
Territorial entities Coefficient
Boyacá -,136
Risaralda -,113
Vichada -,095

*. The correlation is significant at level 0.05 (bilateral). **. The correlation is significant at level 0.01 (bilateral).

Table 4 Positive Pearson correlation of DALY rates for Tuberculosis in women by territorial entity, Colombia, 2010-2018 

Territorial entities Coefficient
Caquetá ,719*
Cesar ,716*
Guajira ,546
Huila ,480
Caldas ,355
Tolima ,203
Vaupés ,155
Arauca ,138
Sucre ,131
Guaviare ,105
Atlántico ,039
Cundinamarca ,033

*. The correlation is significant at the 0.05 level. **. The correlation is significant at level 0.01.

Discussion

This research presents for the first time for the subnational level of Colombia, the BD attributable to TB in women, measured with the updated methodology with which WHO performs the GBD.

What was found in the study against the low casuistry of TB reported in women, agrees with international studies3, however, it is a significant cause of death among women aged 15-44 years worldwide. This may be the result of consistently lower diagnosis and reporting of TB in women, patterns of social contact21 and low detection22, due to differences in access and care, biological and behavioral factors23, high-incidence environments24, the possibility of underestimation of the load on them25, among others.

TB mortality guides decision-making. Risk factors for TB mortality include late diagnosis, HIV positivity, among others. YLL rates are high and have subnational gaps, which poses a major challenge, considering regional disparities.

Amazonas and Guajira had the highest rates of fatal TB effects measured by YLL, consistent with previous mortality studies conducted in Colombia7,26. This disparity may be contextually entrenched given the particularities of these regions, where factors such as multidimensional poverty, and unequal access to health care are critical. Most health inequalities within countries are explained by population density, income, education and occupation27,28. These territories are highly rural, a higher risk for TB has been described in the literature in rural areas with unbalanced socioeconomic development29. The presence of indigenous population, whose living conditions, health inequalities and stigma can generate crises, is another factor to consider in future research. Other TE such as Vichada and Guaviare share similar geographical and population conditions, however, there are low or no reports of cases. In the case of Vichada, the underreporting of mortality in women, estimated for its vital statistics system, was 64%, while in men it was 49%, evidencing the possibility of underreporting of mortality from TB30 in this entity. In addition to the above, in the BD study conducted for the Colombian Orinoquia, the rate of YLL in women from Vichada was 124.1 (II95% 9.9-366.9) for 2017, which may be due to the adjustment for completeness that was made in that study6 that did not differentiate events, however, in our study Vichada did not report deaths.

These findings underscore the influence of the social environment on TB distribution and the need to identify economic and social barriers to accessing care, which in this study we cannot explore further, given the available data.

In terms of non-fatal effects of TB measured by YLD, Amazonas and Guaviare had the highest rates. These entities share structural and intermediate social determinants. Gender inequalities as a proximal determinant can interact with other determinants and respond to social norms, roles and status26, where women face barriers such as stigma within the home, lack of financial independence, among others. Studies in Colombia show marked educational inequalities in women regarding TB26, perhaps this is a likely explanation in these regions. Health literacy is considered an indicator of the use of health care services and low literacy can translate into underutilized preventive services31. Another explanatory route may be related to resilience 32 and that it has a direct relationship between its levels and positive health conditions33. The social permeability that captures the "mix" between ages and genders and patterns of traveling locals34 it may be another figuration. Another hypothetical mechanism may be immunity compressed by prolonged exposure to psychosocial stress that induces physiological wear and tear and leads to decreased immune function35.

The demographic structure of the population is known as a key determinant of the spread of infectious diseases36. The concentration of DALYs in women of childbearing age, which is also the economically active population, is a relevant finding given the increased likelihood of presenting TB-HIV coinfection and developing severe forms of TB37,38. It is also important, due to the possibility of pregnancies in this age group. Pregnancy leads to a state of relative immunosuppression and a theoretically increased probable susceptibility to activation or infection by intracellular microbes such as TB-causing Mycobacterium tuberculosis39. Another hypothesis could be that the burden of domestic work and childcare is added, which allows them little time to access medical care, which leads to a greater BD.

Although this research did not contemplate differential analysis between pregnant women or women with newborn children, it is a relevant factor to consider for future research. This is due to the fact that being mothers with TB they have a higher risk of transmitting the infection to the child, increasing the risk of complications due to prenatal care and postnatal morbidity, a situation reported especially in developing countries40. Another important aspect is related to the importance of the carcinogenic effect of TB, considering that 1.61% of cancers could be attributed to TB41, so the burden of TB in women should raise awareness about it.

Territorial differences show data of success or progress in some that reflect, at least hypothetically, improved participation of community organizations and workers, as well as the involvement of the private sector expanding TB care. Likewise, entities that show a stagnation or tendency to decrease, perhaps due to the seriousness of their social problems or the deficit of institutional or programmatic capacities, prevent them from facing the burden they have, as well as the differences between the needs of citizens and the improvement of capacities for their approach42. Another explanatory route for these regional discrepancies may be differences in environmental, demographic, behavioral, and socioeconomic factors, which may include inadequate accessibility to health services and housing conditions43. Perhaps the differences between regions such as Valle and Caquetá are due to less access to treatment and prevention services given cultural norms and inequalities, delays in diagnosis and the lower effectiveness of services due to stigmatization44, the difficulties of integrating TB services with services such as sexual and reproductive, maternal and child health, deterrence due to low privacy or lack of childcare facilities, among others. In a study carried out in four Colombian cities, including the capitals of Valle and Caquetá, it was found that, for example, there is a perception that TB does not exist in Caquetá, which could, together with what has been described above, explain the differences found45. This same study shows in the Valley the creation of intersectoral alliances, monitoring and follow-up to the strategic plan, research and knowledge management, strategies such as community peers and positioning of the process, a situation not reported for Caquetá.

Given the focus of screening commonly towards areas with high rates of case reporting, disparities can be exacerbated by excluding areas that already face barriers to accessing diagnostic services.

Social permeability as an important factor could be explored further, integrating community-level typologies with genomic techniques to map the introduction of strains and chains of community transmission. A regionally balanced and culturally appropriate approach is needed, which, together with the performance of screening as a tracer indicator, helps programmes prioritize areas where screening activities can have the greatest impact. It is essential to integrate the most vulnerable groups, address and remedy social inequalities and, intersectorally, positively mobilize the social determinants of health, given the paradigm of TB as an infectious disease with a high social component.

Finally, the research described here is important to fill the knowledge gap on the use of DALYs as a composite indicator, which in addition to resolving the antagonisms for decision-making generated by simple indicators, unifies the quantification in the same unit of measurement of morbidity as a suboptimal health status and mortality as the time lost when dying before reaching life expectancy6. Additionally, to fill the knowledge gap on finding the causes of subnational gaps in TB disease burden in women.

The findings of this study may allow the planning of effective interventions that consider differences in women's habits and risk factors. They also underscore the importance of considering gender, ethnic and socioeconomic differences in the formulation of public policies for TB control. It can build on the analysis and results of this research and, consequently, reorient current policies or implement public policies, to improve health and eliminate disparities in women.

The possible limitations of this research may be related to the use of secondary data, which as far as possible, were solved with the validation process and bias control.

References

1. Noubiap JJ, Nansseu JR, Nyaga UF, Nkeck JR, Endomba FT, Kaze AD, Agbor VN, Bigna JJ. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 23 million patients with tuberculosis. Lancet Glob Health. 2019 Apr;7(4):e448-e460. doi: 10.1016/S2214-109X(18)30487-X. Epub 2019 Feb 25. PMID: 30819531. [ Links ]

2. World Health Organization. Coronavirus (COVID-19) dashboard [website]. Geneva: World Health Organization (https://covid19.who.int/). https://covid19.who.int/. 2020. [ Links ]

3. Organización Mundial de la Salud Informe Mundial sobre la Tuberculosis. 2020. https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf. [accessed on 14 Dec 2022]. [ Links ]

4. Ministerio de Salud y Protección Social. Informe del evento Tuberculosis 2021. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ET/comportamiento-tuberculosis-2020.pdf. [accessed on 1 Dec 2022]. [ Links ]

5. Silva DR, Muñoz-Torrico M, Duarte R, Galvão T, Bonini EH, Arbex FF, Arbex MA, Augusto VM, Rabahi MF, Mello FCQ. Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs. J Bras Pneumol. 2018 Apr;44(2):145-152. doi: 10.1590/s1806-37562017000000443. PMID: 29791552; PMCID: PMC6044656. [ Links ]

6. Gutiérrez-Lesmes O and Grisales-Romero H. Burden of disease in Colombian Orinoquia, 2017 [version 1; peer review: awaiting peerreview]. F1000Research 2022, 11:1257 (https://doi.org/10.12688/f1000research.124503.1). [ Links ]

7. Plata-Casas L, Gutierrez-Lesmes O, Cala-Vitery F. Tuberculosis Disability Adjusted Life Years, Colombia 2010-2018. Trop Med Infect Dis. 2022 Sep 18;7(9):250. doi: 10.3390/tropicalmed7090250. PMID: 36136661; PMCID:PMC9505559. [ Links ]

8. Plata-Casas L, González-Támara L, Cala-Vitery F. Tuberculosis Mortality in Children under Fifteen Years of Age: Epidemiological Situation in Colombia, 2010-2018. Trop Med Infect Dis. 2022 Jun 25;7(7):117. doi: 10.3390/tropicalmed7070117. PMID: 35878129; PMCID: PMC9319292. [ Links ]

9. World Health Organization. Tuberculosis in women. https://www.who.int/publications/m/item/tuberculosis-in-women. [accessed on 2 Dec 2022]. [ Links ]

10. Stop TB partnership. Gender and TB. 2021. https://stoptb.org/assets/documents/global/awards/tbreach/TB-REACH_Gender2021-web.pdf. [accessed on 1 Dec 2022]. [ Links ]

11. Food and Agriculture Organization of the United Nations. Gender Equality and Women's Empowerment in the context of Food Security and Nutrition. https://www.fao.org/fileadmin/templates/cfs/Docs1920/Gender/GEWE_Scoping_Paper-FINAL040ct.pdf. [accessed on 11 Dec2022]. [ Links ]

12. UNESCO. Girls' and women's literacy with a lifelong learning perspective: issues, trends and implications for the Sustainable Development Goals.2016. https://unesdoc.unesco.org/ark:/48223/pf0000244959. [accessedon 10 Dec 2022]. [ Links ]

13. Stop TB partnership. Género y TB. 2020. https://stoptb.org/assets/documents/communities/CRG_Investment_Package_Gender_and_TB_06.07.2020_ES.pdf. [accessed on 30 Nov 2022]. [ Links ]

14. Hermans S, Cornell M, Middelkoop K, Wood R. The differential impact of HIV and antiretroviral therapy on gender-specific tuberculosis rates. Trop Med Int Health. 2019 Apr;24(4):454-462. doi: 10.1111/tmi.13209. Epub 2019 Feb 14. PMID: 30681241; PMCID: PMC6555136. [ Links ]

15. Krishnan L, Akande T, Shankar AV, et al. Gender-related barriers and delays in accessing tuberculosis diagnostic and treatment services: a systematic review of qualitative studies. Tuberc Res Treat. 2014;2014:215059.doi:10.1155/2014/215059 [ Links ]

16. Agence Française de developpment. Diagnóstico Multidimensional sobre las Desigualdades en Colombia. https://www.repository.fedesarrollo.org.co/handle/11445/4338. [accessed on 7 Dec 2022]. [ Links ]

17. De Santacruz C, Chavarro-Carvajal D, Venegas-Sanabria L, Gama A, Cano Gutiérrez C. Inequalities between Women and Men Aged Over and Under Seventy Years. SABE Colombia - Survey on Health, Well-being and Aging 2015 a. 2019. Universitas Medica: 60(3). [ Links ]

18. World Heatlh Organization. WHO Methods and data sources for global burden of disease estimates 2000-2015. In: Department of Information EaRW, Geneva, editor: Global Health Estimates Technical Paper WHO/HIS/IER/GHE/. 2017. p. 52. https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_daly-methods.pdf?sfvrsn=31b25009_7. [ Links ]

19. Ramon Martinez, Patricia Soliz, Roberta Caixeta, Pedro Ordunez, Reflection on modern methods: years of life lost due to premature mortality-a versatile and comprehensive measure for monitoring non-communicable disease mortality, International Journal of Epidemiology, Volume 48, Issue 4, August 2019, Pages 1367-1376, https://doi.org/10.1093/ije/dyy254. [ Links ]

20. Dicker D, Nguyen G, Abate D, Abate KH, Abay SM, Abbafati C, et al. Supplement to: GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. The lancet. 2018; 392(10159):1684-52. DOI:10.1016/S0140-6736(18)31891-9. DOI: https://doi.org/10.1016/S0140-6736(18)31891-9. [ Links ]

21. Shaweno D, Horton KC, Hayes RJ, Dodd PJ. Assortative social mixing and sex disparities in tuberculosis burden. Sci Rep. 2021;11(1):7530. Published 2021 Apr 6. doi:10.1038/s41598-021-86869-w. [ Links ]

22. Saunders MJ, Tovar MA, Collier D, Baldwin MR, Montoya R, Valencia TR, Gilman RH, Evans CA. Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort study. Lancet Infect Dis. 2019 May;19(5):519-528. doi: 10.1016/S1473-3099(18)30753-9. Epub 2019 Mar 22. PMID: 30910427; PMCID: PMC6483977. [ Links ]

23. Nhamoyebonde S, Leslie A. Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis. 2014 Jul 15;209 Suppl 3:S100-6. doi: 10.1093/infdis/jiu147. PMID: 24966189. [ Links ]

24. Mathema B, Andrews JR, Cohen T, Borgdorff MW, Behr M, Glynn JR, Rustomjee R, Silk BJ, Wood R. Drivers of Tuberculosis Transmission. J Infect Dis. 2017 Nov 3;216(suppl_6):S644-S653. doi: 10.1093/infdis/jix354. PMID: 29112745; PMCID: PMC5853844. [ Links ]

25. Ramos JM, Comeche B, Tesfamariam A, Reyes F, Tiziano G, Balcha S, Edada T, Biru D, Pérez-Butragueño M, Górgolas M. Sex differences and HIV status of tuberculosis in adults at a rural hospital in southern Ethiopia: an 18-year retrospective cross-sectional study. Afr Health Sci. 2020 Jun;20(2):605-614. doi: 10.4314/ahs.v20i2.8. PMID: 33163021; PMCID:PMC7609105. [ Links ]

26. Valencia-Aguirre S, Arroyave I, García-Basteiro AL. Educational level and tuberculosis mortality in Colombia: growing inequalities and stagnation in reduction. Cad Saude Publica. 2022 Jan 31;38(1):e00031721. doi: 10.1590/0102-311X00031721. PMID: 35107505.L. Plata-Casas, et al [ Links ]

27. Wang Q, Guo L, Wang J, Zhang L, Zhu W, Yuan Y, et al. Spatial distribution of tuberculosis and its socioeconomic influencing factors in mainland China 2013-2016. Tropical Medicine and International Health. 2019 Sep 1;24(9):1104-13. https://doi.org/10.1111/tmi.13289Links ]

28. Pini A, Stenbeck M, Galanis I, Kallberg H, Danis K, Tegnell A, et al. Socioeconomic disparities associated with 29 common infectious diseases in Sweden, 2005-14: an individually matched case-control study. Lancet Infect Dis. 2019 Feb 1;19(2):165-76. DOI: https://doi.org/10.1016/S1473-3099(18)30485-7Links ]

29. Wang, L., Xu, C., Hu, M. et al. Spatio-temporal variation in tuberculosis incidence and risk factors for the disease in a region of unbalanced socioeconomic development. BMC Public Health 21, 1817 (2021). https://doi.org/10.1186/s12889-021-11833-2. [ Links ]

30. Gutierrez Lesmes O, Grisales Romero H. Completitud de los reportes de mortalidad en el sistema de estadísticas vitales en la Orinoquía colombiana, 2017. Rev. salud pública [Internet]. [accessed on 8 Dec 2022]. 22(4):407-13. https://revistas.unal.edu.co/index.php/revsaludpublica/article/view/86460Links ]

31. Bragazzi NL, Martini M, Mahroum N. Social determinants, ethical issues and future challenge of tuberculosis in a pluralistic society: the example of Israel. J Prev Med Hyg. 2020 Apr 30;61(1 Suppl 1):E24-E27. doi: 10.15167/2421-4248/jpmh2020.61.1s1.1443. PMID: 32529102; PMCID:PMC7263062. [ Links ]

32. Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76-82. doi: 10.1002/da.10113. PMID: 12964174. [ Links ]

33. Schilling EA, Aseltine RH Jr, Gore S. Adverse childhood experiences and mental health in young adults: a longitudinal survey. BMC Public Health. 2007;7:30. Published 2007 Mar 7. doi:10.1186/1471-2458-7-30. [ Links ]

34. Murray EJ, Dodd PJ, Marais B, Ayles H, Shanaube K, Schaap A, White RG, Bond V. Sociological variety and the transmission efficiency of Mycobacterium tuberculosis: a secondary analysis of qualitative and quantitative data from 15 communities in Zambia. BMJ Open. 2021 Dec 14;11(12):e047136. doi: 10.1136/bmjopen-2020-047136. PMID: 34907038; PMCID: PMC8671921. [ Links ]

35. Sweetland, A; Kritski, A; Oquendo, M; Sublette, M; Norcini, A; Batista-Silva,L;, Karpati, A; Silva, C; Moraes, M; Lapa e Silva, J; Wainberg, L. Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic. Int J Tuberc Lung Dis. 2017: 21(8):852-861.https://www.ingentaconnect.com/content/iuatld/ijtld/2017/00000021/00000008/art00005#Links ]

36. Geard N, Glass K, McCaw JM, McBryde ES, Korb KB, Keeling MJ, McVernon J. The effects of demographic change on disease transmission and vaccine impact in a household structured population. Epidemics. 2015 Dec;13:56-64. doi: 10.1016/j.epidem.2015.08.002. Epub 2015 Sep 2. PMID: 26616042. [ Links ]

37. Maheen Humayun, Joconiah Chirenda, Wen Ye, Innocent Mukeredzi, Hilda Angela Mujuru, Zhenhua Yang, Effect of Gender on Clinical Presentation of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection, Open Forum Infectious Diseases, Volume 9, Issue 10, October 2022, ofac512, https://doi.org/10.1093/ofid/ofac512Links ]

38. Ben Jmaa M, Ben Ayed H, Koubaa M, Hammami F, Damak J, Ben Jemaa M. Is there gender inequality in the epidemiological profile of tuberculosis? Tunis Med. 2020 Mar;98(3):232-240. PMID: 32395817. [ Links ]

39. Fröberg G, Jansson L, Nyberg K, Obasi B, Westling K, Berggren I, Bruchfeld J. Screening and treatment of tuberculosis among pregnant women in Stockholm, Sweden, 2016-2017. Eur Respir J. 2020 Mar 20;55(3):1900851. doi: 10.1183/13993003.00851-2019. PMID: 31949114. [ Links ]

40. Rao S. Tuberculosis and patient gender: An analysis and its implications in tuberculosis control. Lung India. 2009;26(2):46-47. doi:10.4103/0970-2113.48897. [ Links ]

41. Leung, C.Y., Huang, HL., Rahman, M.M. et al. Cancer incidence attributable to tuberculosis in 2015: global, regional, and national estimates. BMC Cancer 20, 412 (2020). https://doi.org/10.1186/s12885-020-06891-5. [ Links ]

42. Espinosa-Arana M, Ortiz-Ruiz N, Diaz-Grajales C, Carvajal-Barona R, Zamudio-Espinoza D, Lina-Miranda L. Procesos y capacidades en la Estrategia Alto a la Tuberculosis Valle del Cauca - Colombia. Rev Cubana Salud Pública. 2021. V. 47 (1) e1332. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662021000100002&lng=es&nrm=iso>. [accessed on 18 Dec 2022]. Epub 01-Mar-2021. [ Links ]

43. Zhong W, Bragazzi NL, Kong JD, Safiri S, Behzadifar M, Liu J, Liu X, Wang W. Burden of Respiratory Infection and Tuberculosis Among US States from 1990 to 2019. Clin Epidemiol. 2021 Jun 29;13:503-514. doi: 10.2147/CLEP.S314802. PMID: 34234569; PMCID: PMC8254524. [ Links ]

44. Cremers AL, de Laat MM, Kapata N, Gerrets R, Klipstein-Grobusch K, Grobusch MP. Assessing the consequences of stigma for tuberculosis patients in urban Zambia. PLoS One. 2015 Mar 25;10(3):e0119861. doi: 10.1371/journal.pone.0119861. PMID: 25806955; PMCID: PMC4373828. [ Links ]

45. Rueda ZV, Ruiz Manco Y, Elena B, Ochoa M. Mitos y realidades sobre la tuberculosis en Colombia. Editorial Universidad Pontificia Bolivariana: 2021 https://repository.upb.edu.co/bitstream/handle/20.500.11912/9312/Tuberculosis_Mitos_Realidades.pdf?sequence=1&isAllowed=yLinks ]

Cómo citar este artículo: L. Plata-Casas, et al. The burden of tuberculosis disease in women, Colombia 2010-2018. Infectio 2023; 27(3): 165-172 https://doi.org/10.22354/24223794.1141

Ethical considerations

Funding. This research received no external funding

Authors contribution. LP designed the study, obtained the databases from the Ministry of Health and Social Protection, examined the databases for analysis, and carried out the statistical analyses led by OG. LP, OG and FC interpreted the results, prepared, reviewed, and wrote the manuscript. All authors reviewed the manuscript and approved the final version. All authors have read and agreed to the published version of the manuscript.

Received: December 22, 2022; Accepted: July 10, 2023

* Autor para correspondencia: Correo electrónico: Laurai.platac@utadeo.edu.co

This study met all the requirements of Resolution 8430 of 1993 for health research in Colombia. Access was granted to the authors under the terms of article 10 of Law 1581 of 2012 and under the legal considerations indicated by the Constitutional Court in judgment C748 of 2011. Confidentiality was safeguarded by not using names or identity numbers.

Conflicts of interest.

The authors declare that they have no conflict of interest

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License